Table of Contents Author Guidelines Submit a Manuscript
International Journal of Reproductive Medicine
Volume 2014, Article ID 581451, 5 pages
http://dx.doi.org/10.1155/2014/581451
Clinical Study

Comparison of IVF Outcomes between Minimal Stimulation and High-Dose Stimulation for Patients with Poor Ovarian Reserve

1CReATe Fertility Centre, 790 Bay Street, Suite 1100, Toronto, ON, Canada M5G 1N8
2Department of Obstetrics & Gynecology, University of Toronto, Toronto, ON, Canada M5S 2J7
3Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Women’s College Hospital, Toronto, ON, Canada M5S 1B2

Received 3 June 2014; Revised 5 September 2014; Accepted 5 September 2014; Published 1 October 2014

Academic Editor: Hind A. Beydoun

Copyright © 2014 Tal Lazer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Kyrou, E. M. Kolibianakis, C. A. Venetis, E. G. Papanikolaou, J. Bontis, and B. C. Tarlatzis, “How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis,” Fertility and Sterility, vol. 91, no. 3, pp. 749–766, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Vollenhoven, T. Osianlis, and J. Catt, “Is there an ideal stimulation regimen for IVF for poor responders and does it change with age?” Journal of Assisted Reproduction and Genetics, vol. 25, no. 11-12, pp. 523–529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. R. Klinkert, F. J. M. Broekmans, C. W. N. Looman, J. D. F. Habbema, and E. R. te Velde, “Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial,” Human Reproduction, vol. 20, no. 3, pp. 611–615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. F. Mutlu, M. Erdem, A. Erdem et al., “Antral follicle count determines poor ovarian response better than anti-müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles,” Journal of Assisted Reproduction & Genetics, vol. 30, no. 5, pp. 657–665, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Zarek and S. J. Muasher, “Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited,” Fertility & Sterility, vol. 95, no. 8, pp. 2449–2455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. R. Klinkert, F. J. M. Broekmans, C. W. N. Looman, and E. R. Te Velde, “A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles,” Fertility and Sterility, vol. 81, no. 5, pp. 1247–1253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. S. Surrey and W. B. Schoolcraft, “Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques,” Fertility and Sterility, vol. 73, no. 4, pp. 667–676, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. M. F. M. Mitwally and R. F. Casper, “Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate,” Fertility and Sterility, vol. 75, no. 2, pp. 305–309, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Yarali, I. Esinler, M. Polat, G. Bozdag, and B. Tiras, “Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol,” Fertility & Sterility, vol. 92, no. 1, pp. 231–235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Healey, S. L. Tan, T. Tulandi, and M. M. Biljan, “Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination,” Fertility and Sterility, vol. 80, no. 6, pp. 1325–1329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. F. Casper and M. F. M. Mitwally, “Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome,” Clinical Obstetrics and Gynecology, vol. 54, no. 4, pp. 685–695, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. P. Ferraretti, A. La Marca, B. C. J. M. Fauser, B. Tarlatzis, G. Nargund, and L. Gianaroli, “ESHRE consensus on the definition of 'poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria,” Human Reproduction, vol. 26, no. 7, pp. 1616–1624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. V. A. Akande, C. F. Fleming, L. P. Hunt, S. D. Keay, and J. M. Jenkins, “Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment,” Human Reproduction, vol. 17, no. 8, pp. 2003–2008, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Nargund, W. C. Cheng, and J. Parsons, “The impact of ovarian cystectomy on ovarian response to stimulation during in-vitro fertilization cycles,” Human Reproduction, vol. 11, no. 1, pp. 81–83, 1996. View at Google Scholar · View at Scopus
  15. S. D. Keay, N. H. Liversedge, and J. M. Jenkins, “Could ovarian infection impair ovarian response to gonadotrophin stimulation?” British Journal of Obstetrics & Gynaecology, vol. 105, no. 3, pp. 252–254, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Nikolaou and A. Templeton, “Early ovarian ageing: a hypothesis: detection and clinical relevance,” Human Reproduction, vol. 18, no. 6, pp. 1137–1139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Garcia-Velasco, L. Moreno, A. Pacheco et al., “The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study,” Fertility and Sterility, vol. 84, no. 1, pp. 82–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. G. Hillier, “Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis,” Human Reproduction, vol. 9, no. 2, pp. 188–191, 1994. View at Google Scholar · View at Scopus
  19. S. Weil, K. Vendola, J. Zhou, and C. A. Bondy, “Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 8, pp. 2951–2956, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Gleicher and D. H. Barad, “Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR),” Reproductive Biology and Endocrinology, vol. 9, article 67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. S. Corfman, M. P. Milad, T. L. Bellavance, S. J. Ory, L. D. Erickson, and G. D. Ball, “A novel ovarian stimulation protocol for use with the assisted reproductive technologies,” Fertility and Sterility, vol. 60, no. 5, pp. 864–870, 1993. View at Google Scholar · View at Scopus
  22. H. Al-Fozan, M. Al-Khadouri, S. L. Tan, and T. Tulandi, “A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation,” Fertility and Sterility, vol. 82, no. 6, pp. 1561–1563, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. I. A. Mohsen and R. E. El Din, “Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI,” Gynecological Endocrinology, vol. 29, no. 2, pp. 105–108, 2013. View at Publisher · View at Google Scholar · View at Scopus